Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways
Su Jung Oh(Innsbruck Medical University), Zoran Čulig(Innsbruck Medical University)
Cited by 65
Related Papers
Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours
|Endocrine Related Cancer|2005|94
Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases
|American Journal Of Pathology|2009|67
Suppressor of Cytokine Signaling-3 Antagonizes cAMP Effects on Proliferation and Apoptosis and Is Expressed in Human Prostate Cancer
|American Journal Of Pathology|2006|59
SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling
|Endocrine Related Cancer|2010|41
p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer
|Endocrine Related Cancer|2020|28